https://www.nxtpsychedelics.com/news/articles/public-companies/small-pharma-reports-positive-top-line-data-from-spl026-dmt-ssri-drug-interaction-study-in-patients-with-major-depressive-disorder/
Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder